Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.31 +0.59 (+2.13%)
Streaming Delayed Price Updated: 12:48 PM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,598,430
Open 27.83
Bid (Size) 28.30 (11)
Ask (Size) 28.31 (20)
Prev. Close 27.72
Today's Range 27.80 - 28.31
52wk Range 25.20 - 37.80
Shares Outstanding 5,606,688,356
Dividend Yield 5.79%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
S&P 500 2024 Q2 Earnings Preview: Aggregate Earnings Reaching A New High Watermark?
Q2 estimates have been stable heading into earnings season, potentially setting a lower bar for corporations to beat analyst expectations and surprise to the upside. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 No-Brainer Stocks to Buy With $100 Right Now
You don't need a mountain of cash to grow your wealth on Wall Street. 
Via The Motley Fool

Performance

YTD
-4.78%
-4.78%
1 Month
+0.86%
+0.86%
3 Month
+5.71%
+5.71%
6 Month
-3.71%
-3.71%
1 Year
-20.66%
-20.66%

More News

Read More
Pfizer Launches Process To Identify Chief Scientific Officer Successor
Via Benzinga
The 3 Most Undervalued Large-Cap Stocks to Buy in July 2024
Via InvestorPlace
Pfizer Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
What the Options Market Tells Us About Pfizer
Via Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Names Four New Members to Executive Team
Via Investor Brand Network
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development
From Pfizer Inc.
Via Business Wire
FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment
Via AB Newswire
Exposures COVID-19 Product Safety
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
Via Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
Via InvestorPlace
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock
Via The Motley Fool
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
Via The Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Via Benzinga
Topics ETFs
3 Bargain Stocks With the Potential for Mind-Boggling Returns
Via InvestorPlace
MarketBeat Week in Review – 7/1 - 7/5
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
Via The Motley Fool
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Via Benzinga
3 Stock Giants Analysts Are Bullish On Despite Struggles
Via MarketBeat
3 Dividend Stocks That Are Screaming Buys in July
Via The Motley Fool
Upcoming Stock Spinoffs: Should You Pounce or Pass?
Via InvestorPlace
7 Juicy Dividend Stocks That Have Grown for More Than a Decade
Via InvestorPlace
How To Buy Growth Stocks In An Economy That Isn’t Growing
Via Talk Markets
Topics Economy Stocks
Exposures Economy US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.